Balchem (NASDAQ:BCPC) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS

Balchem (NASDAQ:BCPC) issued its quarterly earnings results on Friday. The basic materials company reported $1.03 earnings per share for the quarter, missing the consensus estimate of $1.11 by ($0.08), Zacks reports. Balchem had a return on equity of 10.99% and a net margin of 12.90%.

Balchem Stock Up 1.5 %

Shares of NASDAQ:BCPC opened at $163.72 on Friday. Balchem has a 52-week low of $137.69 and a 52-week high of $186.03. The stock has a market cap of $5.32 billion, a P/E ratio of 44.01, a price-to-earnings-growth ratio of 4.41 and a beta of 0.69. The business’s 50 day moving average is $162.20 and its 200 day moving average is $169.32. The company has a quick ratio of 1.90, a current ratio of 2.98 and a debt-to-equity ratio of 0.21.

Balchem Increases Dividend

The company also recently disclosed an annual dividend, which was paid on Friday, January 17th. Investors of record on Thursday, December 26th were paid a $0.87 dividend. The ex-dividend date was Thursday, December 26th. This represents a yield of 0.4%. This is a boost from Balchem’s previous annual dividend of $0.79. Balchem’s dividend payout ratio is 23.39%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. StockNews.com upgraded Balchem from a “hold” rating to a “buy” rating in a report on Monday, October 28th. HC Wainwright increased their price target on Balchem from $185.00 to $190.00 and gave the stock a “buy” rating in a report on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.